Randomized Phase III Study of Sequential Radiochemotherapy of Anaplastic Glioma With PCV or Temozolomide

NCT00717210 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

318

Enrollment

NETWORK

Sponsor class

Conditions

Anaplastic Astrocytoma
Oligodendroglioma
Oligoastrocytoma

Interventions

DRUG: Temozolomide
RADIATION: Focal radiotherapy

Sponsor

Neuro-Oncology Working Group of the German Cancer Society

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]